Multiple Sclerosis Flashcards

1
Q

What is MS?

A

Acquired, chronic, immune-mediated, inflammatory disease of the CNS (can affect brain, brainstem, + spinal cord)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do the inflammatory processes in MS cause pathophysiologically?

A

Areas of demyelination (damage to white matter), gliosis (scarring), + neuronal damage throughout the CNS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the epidemiology of MS

A

F > M (3:1)
Age of onset: 20-40y
More common at high latitudes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What causes MS?

A

UNKNOWN
Acute then chronic inflammation precipitated by abnormal response to environmental triggers in genetically pre-disposed

Immune-mediated damage to myelin sheaths results in impaired axonal conduction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List 2 risk factors for MS

A

FH
Female

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List 3 types of MS

A

Relapsing-Remitting (RRMS)

Primary Progressive (PPMS)

Secondary Progressive (SPMS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe RRMS

A

Most common, 85% have RRMS at onset
Attacks (1-2 months) with almost complete recovery between attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe SPMS

A

gradual accumulation of disability after initial relapsing course
2/3 of RRMS progress to SPMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe PPMS

A

Steady progression + worsening of disease from the onset, without remissions.
~10-15% of MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define ‘relapse’ of MS

A

Onset of new Sx, or worsening of pre-existing Sx.
Attributable to demyelinating disease.
Lasting >24 h
In absence of infection, or any other cause.
After a stable period of at least a month.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What do symptoms depend on in MS?

A

Site of inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List the 4 most common initial presentations of MS

A

Optic neuritis
Transverse myelitis
Cerebellar-related Sx
Brainstem syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe optic neuritis

A

Unilateral deterioration of visual acuity + colour vision
Pain behind eye + on eye movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Other than optic neuritis, what are the possible visual manifestations of MS

A

Optic atrophy
Uhthoff’s phenomenon
Internuclear ophthalmoplegia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Uhthoff’s phenomenon?

A

Worsening of vision following rise in body temperature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe fundoscopy in optic neuritis in MS

A

Often normal but disc may appear pale or swollen.
May be RAPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is transverse myelitis?

A

focal inflammation within the spinal cord
Sensory Sx (such as paraesthesia) or Motor Sx (such as weakness)
below level of inflammation
Typically develop over hours or days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How may transverse myelitis manifest?

A

Tight band sensation around the trunk at level of inflammation
Lhermitte’s phenomena
Urinary Sx: urgency, frequency, retention
Focal muscle weakness + reduced sensation below affected spinal level
Muscle tone initially reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is Lhermitte’s phenomena?

A

Shock-like sensation radiating down the spine + into limbs induced by neck flexion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe cerebellar-related symptoms that may arise in MS

A

Ataxia
Vertigo
Clumsiness
Dysmetria

21
Q

Describe how brainstem syndromes may manifest in MS

A

Ataxia
Eye movement abnormalities
Bulbar muscle problems resulting in dysarthria/ dysphagia

22
Q

What are 3 sensory symptoms of MS?

A

Pins + needles
Numbness
Burning

23
Q

What 6 general signs are seen on examination in MS?

A

Sensory: Paraesthesia
Motor: Spastic weakness most commonly seen in legs
Cerebellar: Limb ataxia (intention tremor, past-pointing)
Urinary frequency/ incontinence
Sexual dysfunction
Cognitive impairment

24
Q

What is diagnosis based on in MS?

A

Finding 2 or more CNS lesions with corresponding Sx, separated in time + space (McDONALD CRITERIA)
Only a consultant neurologist should make a dx of MS.

25
Q

What is seen on brain MRI in MS?

A

High signal T2 lesions
Periventricular plaques
Dawson fingers: hyper intense lesions perpendicular to corpus callosum

26
Q

What is seen on spine MRI in MS?

A

Demyelinating lesions
esp. in the cervical spinal cord
Gadolinium enhancement shows active lesions

27
Q

What is seen on CSF evaluation in MS?

A

Oligoclonal bands (+ not in serum)
Increased intrathecal synthesis of IgG

28
Q

What investigation can be performed in MS when MRI is contraindicated?

A

Visual evoked potentials: prolongated of conduction (preserved waveform)

Also can perform auditory + somatosensory (painful) evoked potentials but are less commonly abnormal

29
Q

Why may LP be performed in MS?

A

r/o infection/ inflammatory causes

30
Q

What are 4 motor symptoms of MS?

A

Limb weakness
Spasms
Stiffness
Heaviness

31
Q

What are 4 autonomic symptoms of MS?

A

Urinary urgency
Hesitancy
Incontinence
Impotence

32
Q

What may be found on visual fielding testing in MS?

A
Central scotoma (if optic nerve is affected) 
Scotoma = a blind spot in the normal visual field 
Field defects (if optic radiations are affected)
33
Q

What occurs in internuclear ophthalmoplegia?

A

Nystagmus of abducting eye with absent adduction of the other eye
Indicates lesion of contralateral medial longitudinal fasciculus

34
Q

What is Clinically Isolated Syndrome?

A

Single clinical attack of demyelination (does NOT count as MS)
10-50% progress to develop MS

35
Q

Describe management of acute relapse in MS

A

PO/ IV Methylprednisolone for 3-5 days

36
Q

Describe the effect of steroids in acute relapse of MS

A

Shorten duration of relapse but don’t alter degree of recovery

37
Q

What are the indications for using disease modifying drugs in MS?

A

RRMS + 2 relapses in past 2y + able to walk 100m unaided
SPMS + 2 relapses in past 2y + able to walk 10m (aided or unaided)

38
Q

List 5 disease modifying drugs that can be used in MS

A

Natalizumab
Ocrelizumab
Fingolimod
Beta-interferon
Glatiramer acetate

39
Q

Describe management of fatigue in MS once other causes have been excluded

A

Amantadine (specialist initiated)
Mindfulness training + CBT

40
Q

Alongside PT, which drugs are used first line for spasticity in MS?

A

Baclofen
Gabapentin
(diazepam, dantrolene + tizanidine)

41
Q

Describe management of bladder dysfunction in MS

A

US to assess bladder emptying

Significant residual volume → intermittent self-catheterisation

No significant residual volume → anticholinergics may reduce frequency

42
Q

What is Oscillopsia?
What drug can be used to manage this in MS?

A

Where visual fields appear to oscillate
Gabapentin (2nd: memantine)

43
Q

What is Natalizumab? What is the MOA?

A

Recombinant monoclonal antibody
Antagonises alpha-4 beta-1-integrin found on surface of leucocytes
Inhibits migration of leucocytes across the BBB

44
Q

Which disease modifying drug has the strongest evidence base for preventing relapse in MS? What is the mode of delivery?

A

Natalizumab
Often given first line
IV

45
Q

What is Ocrelizumab?

A

Humanized anti-CD20 monoclonal antibody
High-efficacy, often used first-line
IV

46
Q

What is Fingolimid?

A

Sphingosine 1-phosphate (S1P) receptor modulator
Prevents lymphocytes from leaving LNs

PO

47
Q

Describe use of beta interferon in MS

A

Not considered to be as effective as alternative disease-modifying drugs

SC / IM

48
Q

What is Glatiramer acetate?

A

Immunomodulating drug: acts as an ‘immune decoy’
SC
‘older drug’ with less effectiveness